These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10665326)

  • 21. [Long-term beneficial effect of dual chamber pacing in a patient with hypertrophic obstructive cardiomyopathy].
    Takahashi M; Horinaka S; Takada M; Matsumoto N; Tsuchiya N; Yabe A; Onoda M; Murate J; Masuda T; Ishikawa K; Takeda K; Matsuoka H
    J Cardiol; 1997 Jun; 29(6):345-52. PubMed ID: 9211094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of physiological cardiac stimulation in the treatment of hypertrophic obstructive cardiomyopathy].
    Jeanrenaud X; Vogt P; Goy JJ; Kappenberger L
    Schweiz Med Wochenschr; 1992 Apr; 122(16):593-6. PubMed ID: 1579866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short atrioventricular delay pacing therapy in young and old patients with hypertrophic obstructive cardiomyopathy: good long-term results and a low need for reinterventions.
    Javidgonbadi D; Abdon NJ; Andersson B; Schaufelberger M; Östman-Smith I
    Europace; 2018 Oct; 20(10):1683-1691. PubMed ID: 29121221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.
    Slade AK; Sadoul N; Shapiro L; Chojnowska L; Simon JP; Saumarez RC; Dodinot B; Camm AJ; McKenna WJ; Aliot E
    Heart; 1996 Jan; 75(1):44-9. PubMed ID: 8624871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of atrioventricular delay on pulmonary capillary wedge pressure in two patients with hypertrophic obstructive cardiomyopathy during dual chamber pacing].
    Ochiai K; Tanabe K; Yoshitomi H; Kinoshita Y; Kitamura J; Shimizu H; Nakamura K; Sano K; Ishibashi Y; Shimada T
    J Cardiol; 1997 Feb; 29(2):103-9. PubMed ID: 9120791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular endocardial pacing predicts the reduction of left ventricular outflow tract pressure gradient immediately after percutaneous transseptal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
    Chen SL; Dai ZL; Li ZQ; Hu ZY; Ye F; Zhang JJ; Zhang FF; Luo J; Zhu ZS; Lin S; Wu CQ; Tian NL
    Chin Med J (Engl); 2007 Apr; 120(7):562-8. PubMed ID: 17442203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Importance of atrioventricular synchrony in hypertrophic obstructive cardiomyopathy treated by cardiac pacing].
    Gras D; de Place C; Le Breton H; Leclercq C; Paillard F; Mabo P; Daubert C
    Arch Mal Coeur Vaiss; 1995 Feb; 88(2):215-23. PubMed ID: 7487270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-chamber pacing in hypertrophic obstructive cardiomyopathy: a comparison of acute and chronic effects.
    Sakai Y; Kawakami Y; Hirota Y; Ito T; Shimada S; Tokaji Y; Suwa M; Kawamura K; Morimoto T; Nishimoto Y; Sasaki S
    Jpn Circ J; 1999 Dec; 63(12):971-5. PubMed ID: 10614843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertensive left ventricular hypertrophy with left ventricular outflow tract obstructive physiology: a case of successful treatment with dual-chamber pacing.
    Wicks AB; Stajduhar K; Mascette A
    Mil Med; 1998 Dec; 163(12):861-3. PubMed ID: 9866370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic left ventricular outflow tract obstruction due to concentric left ventricular hypertrophy: effect of pacing with a short AV interval.
    Krahn AD; Geddes JS
    Can J Cardiol; 1994 Oct; 10(8):850-2. PubMed ID: 7954021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and echocardiographic variables fail to predict response to dual-chamber pacing for hypertrophic cardiomyopathy.
    Binder J; Ommen SR; Sorajja P; Nishimura RA; Tajik AJ
    J Am Soc Echocardiogr; 2008 Jul; 21(7):796-800. PubMed ID: 18222636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dual-chamber pacemakers in obstructive hypertrophic cardiomyopathy: gradient variation with stress echocardiography].
    Martínez Martínez JG; Ortuño Alcaraz D; Marín Ortuño F; Luján Martínez J; Ibáñez Criado A; Quiles Llorens JA; Sogorb Garri F
    Rev Esp Cardiol; 1998 Jan; 51(1):51-5. PubMed ID: 9580168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy.
    Jeanrenaud X; Goy JJ; Kappenberger L
    Lancet; 1992 May; 339(8805):1318-23. PubMed ID: 1349992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pacemaker therapy in a pediatric patient with hypertrophic obstructive cardiomyopathy and rapid intrinsic atrioventricular conduction.
    Mann C; Antretter H; Hammerer I
    Pediatr Cardiol; 1999; 20(3):229-31. PubMed ID: 10089254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DDDR pacing for symptomatic patients with hypertrophic obstructive cardiomyopathy: The first experience in the Netherlands with pacing in HOCM.
    Achterberg HJ; Scheffer MG; van Mechelen R; Kofflard MJ; Ten Cate FJ
    Neth Heart J; 2002 Jun; 10(6):272-276. PubMed ID: 25696108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy.
    Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L
    J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay.
    Krahn AD; Snell L; Yee R; Finan J; Skanes AC; Klein GJ
    Can J Cardiol; 2002 Apr; 18(4):380-7. PubMed ID: 11992131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New treatment methods for patients with hypertrophic obstructive cardiomyopathy.
    Lakkis N
    Curr Opin Cardiol; 2000 May; 15(3):172-7. PubMed ID: 10952424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of obstructive cardiomyopathy by permanent apical ventricular stimulation].
    Guize L; Iliou MC; Lavergne T; Le Heuzey JY
    Ann Cardiol Angeiol (Paris); 1995 Jan; 44(1):37-40. PubMed ID: 7702354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).
    Maron BJ; Nishimura RA; McKenna WJ; Rakowski H; Josephson ME; Kieval RS
    Circulation; 1999 Jun; 99(22):2927-33. PubMed ID: 10359738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.